TrialHaematologica2018

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the

Sergio Storti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.